EpiTERNA SA
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
EpiTERNA SA - overview
Established
2022
Location
-, -, Switzerland
Primary Industry
Biotechnology
About
Based in Switzerland, and founded in 2022, EpiTERNA SA provides products and research to extend the life of animals and humans. The company was co-founded by Alejandro Ocampo (CEO), and Kevin Perez. In August 2023, Prima Material led a USD EUR 10 million in venture funding for Epiterna SA. The company offers products that help in slowing down the aging process and facilitates the prevention of age-related disease, delay functional decline, and extend life.
The firm’s product is meant for companion dogs, cats, and people. The company plans to use the August 2023 funding to further develop its platform.
Current Investors
Prima Materia
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals
Website
www.epiterna.com
Verticals
Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.